Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 28/2/2020
SIETES contiene 92917 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Sing CW, Wong ICK, Cheung BMY, Chan JCY, Chu JKP, Cheung C-L. Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case–control study. Pharmacoepidemiol Drug Saf 2017;26:248-55. [Ref.ID 101954]
2.Tiene citas relacionadas
Cheung BMY, Lam KSL. Is intensive LDL-cholesterol lowering beneficial and safe?. Lancet 2010;376:1622-4. [Ref.ID 89621]
3.Tiene citas relacionadas Cita con resumen
Cheung BMY. Statins for people with diabetes. Lancet 2008;371:94-5. [Ref.ID 81960]
4.Tiene citas relacionadas
Kumana CR, Cheung BMY, Cheung GTY, Ovedal T, Pederson B, Lauder IJ. Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol 2005;60:347-54. [Ref.ID 75067]
6. Cita con resumen
Cheung BMY, Lauder IJ, Lau C-P, Kumana CR. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular otucomes. Br J Clin Pharmacol 2004;57:640-51. [Ref.ID 70035]
7.Tiene citas relacionadas
Cheung BMY, Kumana CR. Effectiveness of lipid lowering drugs in general practice. Study had two major flaws. BMJ 2003;327:51. [Ref.ID 66775]
8.Tiene citas relacionadas Cita con resumen
Cheung BMY, Kumana CR. Dementia and statins. Lancet 2001;357:880. [Ref.ID 55609]
9. Cita con resumen
Kumana CR, Cheung BMY, Lauder IJ. Gauging the impact of statins using number needed to treat. JAMA 1999;282:1899-901. [Ref.ID 48016]
10.
Cheung BMY, Kumana CR. Natriuretic peptides - relevance in cardiovascular disease. JAMA 1998;280:1983-4. [Ref.ID 42048]
Seleccionar todas
 
 1 a 10 de 10